AI Verdict
LTRX has stronger fundamentals based on our AI analysis.
LTRX vs LTRN Fundamental Comparison
| Metric | LTRX | LTRN |
|---|---|---|
| Revenue | $59.6M | N/A |
| Net Income | $-2.7M | $-17.1M |
| Net Margin | -4.6% | N/A |
| ROE | -3.7% | -262.0% |
| ROA | -2.2% | -155.1% |
| Current Ratio | 2.75x | 2.40x |
| Debt/Equity | 0.13x | 0.00x |
| EPS | $-0.07 | $-1.57 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LTRX vs LTRN: Frequently Asked Questions
Is LTRX or LTRN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LTRX has stronger fundamentals. LTRX is rated SELL (72% confidence) while LTRN is rated STRONG SELL (87% confidence). This is not investment advice.
How does LTRX compare to LTRN fundamentally?
LANTRONIX INC has ROE of -3.7% vs Lantern Pharma Inc.'s -262.0%. Net margins are -4.6% vs N/A respectively.
Which stock pays higher dividends, LTRX or LTRN?
LTRX has a dividend yield of N/A or no dividend while LTRN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LTRX or LTRN for long term?
For long-term investing, consider that LTRX has SELL rating with 72% confidence, while LTRN has STRONG SELL rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LTRX vs LTRN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LTRX vs LTRN, the AI consensus favors LTRX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.